Kelch-like protein 42 is a profibrotic ubiquitin E3 ligase involved in systemic sclerosis [Protein Synthesis and Degradation] (Journal of Biological Chemistry)

Systemic scleroderma (SSc) is an autoimmune disease that affects over 2.5 million people globally. SSc results in dysfunctional connective tissues with excessive profibrotic signaling, affecting skin, cardiovascular, and particularly lung tissue. Over three-quarters of individuals with SSc develop pulmonary fibrosis within 5 years, the main cause of SSc mortality. No approved medicines to manage lung SSc currently exist. Recent research suggests that profibrotic signaling by transforming growth factor ? (TGF-?) is directly tied to SSc. Previous studies have also shown that ubiquitin E3 ligases potently control TGF-? signaling through targeted degradation of key regulatory proteins; however, the roles of these ligases in SSc-TGF-? signaling remain unclear. Here we utilized primary SSc patient lung cells for high-throughput screening of TGF-? signaling via high-content imaging of nuclear translocation of the profibrotic transcription factor SMAD family member 2/3 (SMAD2/3). We screened an RNAi library targeting ubiquitin E3 ligases and observed that knockdown of the E3 ligase Kelch-like protein 42 (KLHL42) impairs TGF-?-dependent profibrotic signaling. KLHL42 knockdown reduced fibrotic tissue production and decreased TGF-?-mediated SMAD activation. Using unbiased ubiquitin proteomics, we identified phosphatase 2 regulatory subunit B`? (PPP2R5?) as a KLHL42 substrate. Mechanistic experiments validated ubiquitin-mediated control of PPP2R5? stability through KLHL42. PPP2R5? knockdown exacerbated TGF-?-mediated profibrotic signaling, indicating a role of PPP2R5? in SSc. Our findings indicate that the KLHL42-PPP2R5? axis controls profibrotic signaling in SSc lung fibroblasts. We propose that future studies could investigate whether chemical inhibition of KLHL42 may ameliorate profibrotic signaling in SSc.